A double-blind comparative study of ketanserin with atenolol in essential hypertension

R. Antonicelli, A. Andreoni, G. Saccomanno, C. Gambini, E. Paciaroni

Research output: Contribution to journalArticle

Abstract

Sixty patients, with mild to moderate essential hypertension, were considered for a double-blind trial comparing the effects of ketanserin and atenolol. After 2 weeks of placebo, a group of 30 patients was given ketanserin 20 mg twice daily 15 days and 40 mg twice daily for the subsequent 45 days, while the second group (30 patients) was given atenolol for 60 days at the dose of 100 mg once daily. Blood pressure and pulse rate in the supine and standing positions were evaluated every 15 days. After the beginning of treatment with ketanserin, there was a gradual but highly significant decrease of the diastolic and systolic blood pressure values. No important side-effects or significant alterations in the biochemical parameters considered were observed during treatment with ketanserin.

Original languageEnglish
Pages (from-to)577-581
Number of pages5
JournalDrugs under Experimental and Clinical Research
Volume15
Issue number11-12
Publication statusPublished - 1989

    Fingerprint

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology (medical)
  • Drug Discovery
  • Pharmacology

Cite this